Table 3 pH correlation to clinical outcome and adverse events
From: Deciphering the importance of culture pH on CD22 CAR T-cells characteristics
Patient | pH | Clinical response | CRS gradea | IEC-HS | Neurotoxicity |
|---|---|---|---|---|---|
5 | Low | – | – | – | – |
18 | Low | – | – | – | – |
11 | Low | No | 0 | No | No |
13 | Low | No | 0 | No | No |
3 | Low | Yes | 2 | Yes | No |
4 | Low | Yes | 1 | No | No |
7 | Low | Yes | 1 | Yes | No |
8 | Low | Yes | 1 | No | No |
12 | Low | Yes | 1 | Yes | No |
16 | Low | Yes | 2 | No | Yes |
19 | Low | Yes | 2 | Yes | No |
20 | Low | Yes | 1 | No | Yes |
10 | High | – | – | – | – |
17 | High | – | – | – | – |
6 | High | No | 1 | No | No |
9 | High | No | 2 | Yes | Yes |
14 | High | No | 1 | No | Yes |
15 | High | No | 1 | No | No |
1 | High | Yes | 2 | Yes | Yes |
2 | High | Yes | 2 | Yes | Yes |